Enhanced platelet responsiveness due to chilling and its relation to D40 ligand level and platelet-leukocyte aggregate formation

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 3, 2009, Pages 176-184

  Ayukawa, Osamu ^a   Nakamura, Kazuo ^b   Kariyazono, Hiroko ^c   Ikeda, Ryuji ^a   Arima, Junko ^a   Shinkawa, Terutoshi ^a   Iwase, Harunobu ^b   Sakata, Ryuzo ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^c NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

CD40 ligand; CD45; Confocal scanning laser microscopy; Flow cytometry; P selectin; Platelet leukocyte aggregates; Platelet rich plasma aggregation; Soluble form of CD40 ligand; Western blotting; Whole blood aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIBODY; CD40 LIGAND; CD45 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE 2; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; THROMBOXANE B2;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CELL STIMULATION; CONTROLLED STUDY; CRYOPRESERVATION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCED HYPOTHERMIA; LEUKOCYTE AGGREGATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE RICH PLASMA;

AGED; BLOOD PLATELETS; BLOOD PRESERVATION; CD40 LIGAND; COLD TEMPERATURE; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION;

EID: 67650888607     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328322ffd5     Document Type: Article

References (38)

1. Choi JW, Pai SH. Influence of storage temperature on the responsiveness of human platelets to agonists. Ann Clin Lab Sci 2003; 33:79-85.
2. White JG, Krivit W. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood 1967; 30:625-635.
3. Fijnheer R, Modderman PW, Veldman H, Ouwehand WH, Nieuwenhuis HK, Roos D, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 1990; 30:20-25.
4. Winokur R, Hartwig JH. Mechanism of shape change in chilled human platelets. Blood 1995; 85:1796-1804.
5. Watts SE, Tunbridge LJ, Smith K, Lloyd JV. Storage of platelets for tests of platelet function: effects of temperature on platelet aggregation, platelet morphology and liberation of beta-thromboglobulin. Thromb Res 1986; 44:365-376.
6. Grewal IS, Flavell RA. CD40 and CD145 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-135.
7. + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992; 175:1091-1101.
8. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357:80-82.
9. Clark EA, Ledbetter JA. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A 1986; 83:4494-4498.
10. Melter M, Reinders ME, Sho M, PalS, GeehanC,Denton MD, et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000; 96:3801-3808.
11. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591-594.
12. Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98:1047-1054.
13. Mach F, Schönbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 1998; 137 (Suppl):S89-S95.
14. Aukrust P, Mü ller F, Ueland T, Berget T, Aaser E, Brunsvig A, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100:614-620.
15. Garlichs CD, Eskafi S, Raaz D, Schmidt A, Ludwig J, Herrmann M, et al. Patients with acute coronary syndromes express enhanced CD40 ligand/ CD154 on platelets. Heart 2001; 86:649-655.
16. Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003; 108:2776-2782.
17. Nannizzi-Alaimo L, Rubenstein MH, Alves VL, Leong GY, Phillips DR, Gold HK. Cardiopulmonary bypass induces release of soluble CD40 ligand. Circulation 2002; 105:2849-2854.
18. 2-receptor antagonists on platelet function in vitro. Hum Exp Toxicol 1999; 18:487-492.
19. Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res 2001; 101:445-453.
20. Stenberg PE, Shuman MA, Levine SP, Bainton DF. Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol 1984; 98:748-760.
21. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986; 78:130-137.
22. Dunlop LC, Skinner MP, Bendall LJ, Favaloro EJ, Castaldi PA, Gorman JJ, et al. Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992; 175:1147-1150.
23. Ishiwata N, Takio K, Katayama M, Watanabe K, Titani K, Ikeda Y, et al. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 1994; 269:23708-23715.
24. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74:626-630.
25. Blann AD, Lip GY, Islim IF, Beevers DG. Evidence of platelet activation in hypertension. J Hum Hypertens 1997; 11:607-609.
26. Daví G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97:953-957.
27. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79:1201-1205.
28. Esposito CJ, Popescu WM, Rinder HM, Schwartz JJ, Smith BR, Rinder CS. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thromb Haemost 2003; 90:1128-1134.
29. Kariyazono H, Nakamura K, Arima J, Ayukawa O, Onimaru S, Masuda H, et al. Evaluation of antiplatelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood. Blood Coagul Fibrinolysis 2004; 15:157-167.
30. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Throm Res 2001; 101:65-72.
31. Sudo T, Ito H, Ozeki Y, Kimura Y. Estimation of antiplatelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001; 133:1396-1404.
32. Ikeda R, Furukawa T, Mitsuo R, Noguchi T, Kitazono M, Okumura H, et al. Thymidine phosphorylase inhibits apoptosis induced by cisplatin. Biochem Biophys Res Commun 2003; 301:358-363.
33. Faraday N, Rosenfeld BA. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology 1998; 88:1579-1585.
34. Owens M, Holme S, Heaton A, Sawyer S, Cardinali S. Posttransfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992; 80:539-544.
35. Tablin F, Oliver AE, Walker NJ, Crowe LM, Crowe JH. Membrane phase transition of intact human platelets: correlation with cold-induced activation. J Cell Physiol 1996; 168:305-313.
36. Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006; 36:201-210.
37. Pamuk GE, Vural O, Turgut B, Demir M, Umit H, Tezel A. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol 2006; 81:753-759.
38. Hughes JD, Macdonald VW, Hess JR. Warm storage of whole blood for 72h. Transfusion 2007; 47:2050-2056.